300381 Stock Overview
Researches, develops, produces, sells, and services biological enzyme preparations, biosynthetics, and nutrition and health products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
Guangdong VTR Bio-Tech Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥7.96 |
| 52 Week High | CN¥9.79 |
| 52 Week Low | CN¥3.53 |
| Beta | 0.35 |
| 1 Month Change | 9.49% |
| 3 Month Change | 39.40% |
| 1 Year Change | 7.86% |
| 3 Year Change | -29.56% |
| 5 Year Change | -20.24% |
| Change since IPO | 18.92% |
Recent News & Updates
Recent updates
Guangdong VTR Bio-Tech Co., Ltd. (SZSE:300381) Looks Inexpensive But Perhaps Not Attractive Enough
Sep 30
Guangdong VTR Bio-Tech's (SZSE:300381) Soft Earnings Are Actually Better Than They Appear
May 02There's No Escaping Guangdong VTR Bio-Tech Co., Ltd.'s (SZSE:300381) Muted Revenues Despite A 35% Share Price Rise
Apr 30Guangdong VTR Bio-Tech Co., Ltd.'s (SZSE:300381) Share Price Boosted 28% But Its Business Prospects Need A Lift Too
Mar 08Shareholder Returns
| 300381 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | -8.7% | -1.9% | -1.2% |
| 1Y | 7.9% | -16.2% | 11.8% |
Return vs Industry: 300381 exceeded the CN Biotechs industry which returned -16.2% over the past year.
Return vs Market: 300381 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 300381 volatility | |
|---|---|
| 300381 Average Weekly Movement | 8.9% |
| Biotechs Industry Average Movement | 8.8% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 300381 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300381's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 1,119 | Derong Zhou | vtrbiotech.com |
Guangdong VTR Bio-Tech Co., Ltd. researches, develops, produces, sells, and services biological enzyme preparations, biosynthetics, and nutrition and health products in China. The company offers feed, energy, washing, food, papermaking, and textile enzymes, as well as biotechnology solutions. It also provides active natural products.
Guangdong VTR Bio-Tech Co., Ltd. Fundamentals Summary
| 300381 fundamental statistics | |
|---|---|
| Market cap | CN¥3.81b |
| Earnings (TTM) | CN¥19.66m |
| Revenue (TTM) | CN¥803.07m |
194.1x
P/E Ratio4.7x
P/S RatioIs 300381 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300381 income statement (TTM) | |
|---|---|
| Revenue | CN¥803.07m |
| Cost of Revenue | CN¥460.15m |
| Gross Profit | CN¥342.92m |
| Other Expenses | CN¥323.26m |
| Earnings | CN¥19.66m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.041 |
| Gross Margin | 42.70% |
| Net Profit Margin | 2.45% |
| Debt/Equity Ratio | 3.4% |
How did 300381 perform over the long term?
See historical performance and comparisonDividends
0.8%
Current Dividend Yield150%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 09:55 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Guangdong VTR Bio-Tech Co., Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jia Chen | Changjiang Securities Co. LTD. |
| Xiao Bao Liu | Everbright Securities Co. Ltd. |
| Baoping Zhang | Founder Securities Co., Ltd. |